Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging

Yeliz Pekcevik, Charles H. Mitchell, Maureen A. Mealy, Gunes Orman, In H. Lee, Scott Newsome, Carol Thompson, Carlos A Pardo-Villamizar, Peter Calabresi, Michael Levy, Izlem Izbudak

Research output: Contribution to journalArticle

Abstract

Background: Although spinal magnetic resonance imaging (MRI) findings of neuromyelitis optica (NMO) have been described, there is limited data available that help differentiate NMO from other causes of longitudinally extensive transverse myelitis (LETM). Objective: To investigate the spinal MRI findings of LETM that help differentiate NMO at the acute stage from multiple sclerosis (MS) and other causes of LETM. Methods: We enrolled 94 patients with LETM into our study. Bright spotty lesions (BSL), the lesion distribution and location were evaluated on axial T2-weighted images. Brainstem extension, cord expansion, T1 darkness and lesion enhancement were noted. We also reviewed the brain MRI of the patients during LETM. Results: Patients with NMO had a greater amount of BSL and T1 dark lesions (p < 0.001 and 0.003, respectively). The lesions in NMO patients were more likely to involve greater than one-half of the spinal cord's cross-sectional area; to enhance and be centrally-located, or both centrally-and peripherallylocated in the cord. Of the 62 available brain MRIs, 14 of the 27 whom were NMO patients had findings that may be specific to NMO. Conclusions: Certain spinal cord MRI features are more commonly seen in NMO patients and so obtaining brain MRI during LETM may support diagnosis.

Original languageEnglish (US)
Pages (from-to)302-311
Number of pages10
JournalMultiple Sclerosis
Volume22
Issue number3
DOIs
StatePublished - 2016

Fingerprint

Transverse Myelitis
Neuromyelitis Optica
Magnetic Resonance Imaging
Spinal Cord
Brain
Darkness
Brain Stem
Multiple Sclerosis

Keywords

  • Brain
  • Diagnostic imaging
  • Lesions
  • Magnetic resonance imaging
  • Neuroimaging
  • Neuromyelitis optica
  • Spinal cord
  • Transverse myelitis

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging. / Pekcevik, Yeliz; Mitchell, Charles H.; Mealy, Maureen A.; Orman, Gunes; Lee, In H.; Newsome, Scott; Thompson, Carol; Pardo-Villamizar, Carlos A; Calabresi, Peter; Levy, Michael; Izbudak, Izlem.

In: Multiple Sclerosis, Vol. 22, No. 3, 2016, p. 302-311.

Research output: Contribution to journalArticle

@article{1ced948f14ae40b5bbb9c4926f254a3b,
title = "Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging",
abstract = "Background: Although spinal magnetic resonance imaging (MRI) findings of neuromyelitis optica (NMO) have been described, there is limited data available that help differentiate NMO from other causes of longitudinally extensive transverse myelitis (LETM). Objective: To investigate the spinal MRI findings of LETM that help differentiate NMO at the acute stage from multiple sclerosis (MS) and other causes of LETM. Methods: We enrolled 94 patients with LETM into our study. Bright spotty lesions (BSL), the lesion distribution and location were evaluated on axial T2-weighted images. Brainstem extension, cord expansion, T1 darkness and lesion enhancement were noted. We also reviewed the brain MRI of the patients during LETM. Results: Patients with NMO had a greater amount of BSL and T1 dark lesions (p < 0.001 and 0.003, respectively). The lesions in NMO patients were more likely to involve greater than one-half of the spinal cord's cross-sectional area; to enhance and be centrally-located, or both centrally-and peripherallylocated in the cord. Of the 62 available brain MRIs, 14 of the 27 whom were NMO patients had findings that may be specific to NMO. Conclusions: Certain spinal cord MRI features are more commonly seen in NMO patients and so obtaining brain MRI during LETM may support diagnosis.",
keywords = "Brain, Diagnostic imaging, Lesions, Magnetic resonance imaging, Neuroimaging, Neuromyelitis optica, Spinal cord, Transverse myelitis",
author = "Yeliz Pekcevik and Mitchell, {Charles H.} and Mealy, {Maureen A.} and Gunes Orman and Lee, {In H.} and Scott Newsome and Carol Thompson and Pardo-Villamizar, {Carlos A} and Peter Calabresi and Michael Levy and Izlem Izbudak",
year = "2016",
doi = "10.1177/1352458515591069",
language = "English (US)",
volume = "22",
pages = "302--311",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging

AU - Pekcevik, Yeliz

AU - Mitchell, Charles H.

AU - Mealy, Maureen A.

AU - Orman, Gunes

AU - Lee, In H.

AU - Newsome, Scott

AU - Thompson, Carol

AU - Pardo-Villamizar, Carlos A

AU - Calabresi, Peter

AU - Levy, Michael

AU - Izbudak, Izlem

PY - 2016

Y1 - 2016

N2 - Background: Although spinal magnetic resonance imaging (MRI) findings of neuromyelitis optica (NMO) have been described, there is limited data available that help differentiate NMO from other causes of longitudinally extensive transverse myelitis (LETM). Objective: To investigate the spinal MRI findings of LETM that help differentiate NMO at the acute stage from multiple sclerosis (MS) and other causes of LETM. Methods: We enrolled 94 patients with LETM into our study. Bright spotty lesions (BSL), the lesion distribution and location were evaluated on axial T2-weighted images. Brainstem extension, cord expansion, T1 darkness and lesion enhancement were noted. We also reviewed the brain MRI of the patients during LETM. Results: Patients with NMO had a greater amount of BSL and T1 dark lesions (p < 0.001 and 0.003, respectively). The lesions in NMO patients were more likely to involve greater than one-half of the spinal cord's cross-sectional area; to enhance and be centrally-located, or both centrally-and peripherallylocated in the cord. Of the 62 available brain MRIs, 14 of the 27 whom were NMO patients had findings that may be specific to NMO. Conclusions: Certain spinal cord MRI features are more commonly seen in NMO patients and so obtaining brain MRI during LETM may support diagnosis.

AB - Background: Although spinal magnetic resonance imaging (MRI) findings of neuromyelitis optica (NMO) have been described, there is limited data available that help differentiate NMO from other causes of longitudinally extensive transverse myelitis (LETM). Objective: To investigate the spinal MRI findings of LETM that help differentiate NMO at the acute stage from multiple sclerosis (MS) and other causes of LETM. Methods: We enrolled 94 patients with LETM into our study. Bright spotty lesions (BSL), the lesion distribution and location were evaluated on axial T2-weighted images. Brainstem extension, cord expansion, T1 darkness and lesion enhancement were noted. We also reviewed the brain MRI of the patients during LETM. Results: Patients with NMO had a greater amount of BSL and T1 dark lesions (p < 0.001 and 0.003, respectively). The lesions in NMO patients were more likely to involve greater than one-half of the spinal cord's cross-sectional area; to enhance and be centrally-located, or both centrally-and peripherallylocated in the cord. Of the 62 available brain MRIs, 14 of the 27 whom were NMO patients had findings that may be specific to NMO. Conclusions: Certain spinal cord MRI features are more commonly seen in NMO patients and so obtaining brain MRI during LETM may support diagnosis.

KW - Brain

KW - Diagnostic imaging

KW - Lesions

KW - Magnetic resonance imaging

KW - Neuroimaging

KW - Neuromyelitis optica

KW - Spinal cord

KW - Transverse myelitis

UR - http://www.scopus.com/inward/record.url?scp=84986563140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986563140&partnerID=8YFLogxK

U2 - 10.1177/1352458515591069

DO - 10.1177/1352458515591069

M3 - Article

VL - 22

SP - 302

EP - 311

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 3

ER -